Search - tctmd.com

Displaying 181 - 200 of 1853

Sort: Relevancy | Date

Presentation THT 2025

The Percutaneous Approach: One Step at a Time…

Presenter: Mark Reisman

February 12, 2025

Presentation THT 2025

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

Presenter: Ryan Tedford

February 12, 2025

Presentation THT 2025

The Surgical Approach: Fix 'Em All At Once!

Presenter: Gilbert Tang

February 12, 2025

Presentation THT 2025

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Putting It All Together: A Case of TTVR

Presenter: Karl-Philipp Rommel

February 12, 2025

Presentation THT 2025

TTVI Trial Updates

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT 2025

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Presenter: Carolyn Lam

February 11, 2025

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation THT 2025

Emerging Questions in the Face of Multiple Effective Therapies

Presenter: Matthew Maurer

February 11, 2025

Presentation THT 2025

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Presenter: Mazen Hanna

February 11, 2025

Presentation THT 2025

Anti-Amyloid Therapy – Will Depleters Change the Game?

Presenter: Scott Solomon

February 11, 2025

Presentation THT 2025

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Presenter: Ahmad Masri

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Presentation THT 2025

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Presenter: Jan Griffin

February 11, 2025

Presentation TCT 2024

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Presenter: Daniel Mitchell

October 30, 2024

Advertisement

The Percutaneous Approach: One Step at a Time…

The HF Physician's Approach: GDMT - Give the Darn Medicines a Try!

The Surgical Approach: Fix 'Em All At Once!

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Putting It All Together: A Case of TTVR

TTVI Trial Updates

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Emerging Questions in the Face of Multiple Effective Therapies

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Anti-Amyloid Therapy – Will Depleters Change the Game?

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Stabilizers for TTR Amyloidosis: Is One Better Than Another

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content